Randi Isaacs
About Randi Isaacs
Chief Medical Officer Randi Isaacs
Randi Isaacs currently serves as the Chief Medical Officer. In this role, she brings a wealth of experience in clinical development and oncology. Her extensive background in both the academic and pharmaceutical industries places her in a strategic position to guide clinical programs and medical strategy effectively. Her leadership is pivotal in advancing the company's medical research and clinical initiatives.
Randi Isaacs' Tenure at Novartis Institutes for Biomedical Research
From May 2010 to November 2020, Randi Isaacs held numerous roles at Novartis Institutes for Biomedical Research. Starting as a Clinical Program Leader, she ascended to positions of increasing responsibility, including Deputy Site Head, and Executive Director and Clinical Site Head of Translational Clinical Oncology. Her tenure at Novartis was marked by her leadership in oncology clinical programs and her contributions to the development of innovative cancer therapies.
Randi Isaacs' Leadership Roles at Merck, Schering Plough, and Sandoz
Before her tenure at Novartis, Randi Isaacs held executive leadership roles in oncology and clinical development at Merck, Schering Plough, and Sandoz. Her work at these companies emphasized her expertise in clinical research and her ability to influence large-scale medical programs. These roles further solidified her reputation as a leader in the field of oncology.
Randi Isaacs' Academic Appointments
Randi Isaacs has held several academic appointments, showcasing her commitment to medical education and research. Notably, she served as an Assistant Professor of Medicine in the Division of Hematology/Oncology at the State University of New York Health Sciences Center and as a Clinical Assistant Professor of Hematology/Oncology at the University of Medicine and Dentistry of New Jersey. Her academic roles involved teaching and mentoring the next generation of medical professionals.
Randi Isaacs' Education and Specialized Training
Randi Isaacs holds a B.A. in Chemistry from Wellesley College and an M.D. with honors from Dartmouth Medical School. She completed her residency and postdoctoral training at the University of California San Francisco and the University of Pennsylvania. Furthermore, she specialized in hematology and medical oncology through fellowship training at Memorial Sloan-Kettering Cancer Center, solidifying her expertise in oncology.